Baker Brothers Advisors - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 222 filers reported holding MIRATI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,410,191
+20.6%
1,409,7840.0%0.35%
+20.0%
Q2 2023$50,935,496
-2.8%
1,409,7840.0%0.30%
+3.5%
Q1 2023$52,415,769
-17.9%
1,409,7840.0%0.28%
-25.8%
Q4 2022$63,877,313
-35.1%
1,409,7840.0%0.38%
-40.5%
Q3 2022$98,459,000
+4.0%
1,409,7840.0%0.64%
+20.1%
Q2 2022$94,639,000
-18.4%
1,409,7840.0%0.54%
-19.4%
Q1 2022$115,912,000
-43.9%
1,409,7840.0%0.67%
-33.8%
Q4 2021$206,801,000
-17.1%
1,409,7840.0%1.01%
-8.1%
Q3 2021$249,405,000
+9.5%
1,409,7840.0%1.10%
+9.5%
Q2 2021$227,722,000
-5.7%
1,409,7840.0%1.00%
-4.5%
Q1 2021$241,496,000
-22.0%
1,409,7840.0%1.05%
-10.3%
Q4 2020$309,645,000
+32.3%
1,409,7840.0%1.17%
+24.8%
Q3 2020$234,095,000
+45.4%
1,409,7840.0%0.94%
+31.7%
Q2 2020$160,955,000
+48.5%
1,409,7840.0%0.71%
+6.4%
Q1 2020$108,370,000
-35.7%
1,409,784
+7.8%
0.67%
-25.6%
Q4 2019$168,448,000
+65.4%
1,307,2200.0%0.90%
+29.3%
Q3 2019$101,846,000
-60.7%
1,307,220
-48.0%
0.69%
-60.6%
Q2 2019$258,887,000
+40.5%
2,513,4620.0%1.76%
+49.2%
Q1 2019$184,237,000
+72.8%
2,513,4620.0%1.18%
+35.1%
Q4 2018$106,621,000
-9.9%
2,513,4620.0%0.87%
+11.9%
Q3 2018$118,384,000
-4.5%
2,513,4620.0%0.78%
-16.2%
Q2 2018$123,914,000
+58.3%
2,513,462
-1.4%
0.93%
+40.4%
Q1 2018$78,268,000
+68.2%
2,549,4610.0%0.66%
+64.5%
Q4 2017$46,528,000
+75.3%
2,549,461
+12.4%
0.40%
+87.4%
Q3 2017$26,549,000
+220.5%
2,269,1980.0%0.22%
+198.6%
Q2 2017$8,283,000
-29.8%
2,269,1980.0%0.07%
-25.8%
Q1 2017$11,800,000
+9.5%
2,269,1980.0%0.10%
-8.5%
Q4 2016$10,779,000
-28.1%
2,269,1980.0%0.11%
-22.1%
Q3 2016$14,999,000
+21.1%
2,269,1980.0%0.14%
+4.6%
Q2 2016$12,390,000
-82.3%
2,269,198
-30.6%
0.13%
-82.4%
Q1 2016$69,947,000
-25.1%
3,268,556
+10.6%
0.74%
-4.7%
Q4 2015$93,380,000
-8.2%
2,955,0740.0%0.77%
-17.7%
Q3 2015$101,714,000
+15.2%
2,955,074
+5.3%
0.94%
+21.4%
Q2 2015$88,276,000
+7.3%
2,805,0740.0%0.77%
+13.2%
Q1 2015$82,245,000
+86.6%
2,805,074
+17.9%
0.68%
+52.0%
Q4 2014$44,079,000
+5.8%
2,380,0740.0%0.45%
-14.3%
Q3 2014$41,675,000
-12.4%
2,380,0740.0%0.52%
-9.9%
Q2 2014$47,601,000
+4.9%
2,380,0740.0%0.58%
+1.0%
Q1 2014$45,388,000
+14.7%
2,380,0740.0%0.58%
+3.4%
Q4 2013$39,581,000
+31.9%
2,380,074
+20.2%
0.56%
+31.0%
Q3 2013$29,998,0001,980,0740.43%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders